Babylon Investor Presentation Deck

Adjusted EBITDA Reconciliation and Calculation of Adjusted EBITDA Margin IFRS Loss for the Period Adjustments to calculate EBITDA: Depreciation and amortization Finance costs and income Tax provision/(benefit) EBITDA Adjustments to calculate Adjusted EBITDA: Recapitalization transaction expense Share-based compensation Change in fair value of warrant liabilities. Gain on remeasurement of equity interest Gain on sale of subsidiary Impairment expense Exchange (gain) / loss Adjusted EBITDA Calculation of Adjusted EBITDA margin: Adjusted EBITDA IFRS Revenue Adjusted EBITDA margin (%) 22 FY2019 (140,287) 2,496 101 (5,559) (143,249) 7,966 (17,075) (152,358) (152,358) 16,034 (950.2)% FY2020 (188,030) 14,487 3,920 4,639 (164,984) 9,557 6,436 2,836 (146,155) (146,155) 79,272 (184.4)% FY2021 (374,511) 35,004 13,965 (1,474) (327,016) 148,722 46,307 (27,811) (10,495) (3,917) 941 (868) (174,137) (174,137) 322,921 (53.9)% Note: See "Item 5. Operating and Financial Review and Prospects--A. Operating Results--Key Business and Financial Metrics--EBITDA and Adjusted EBITDA" in our Form 20-F filed with the SEC on March 30, 2022. We are not able to reconcile projected 2022 Adjusted EBITDA or 2022 Adjusted EBITDA margin to their respective most directly comparable IFRS measures as we are not able to forecast IFRS loss on a forward-looking basis without unreasonable efforts due to the high variability and difficulty in predicting certain items that affect IFRS loss for the period, including, but not limited to, impairment expense, share-based compensation, foreign exchange gains or losses and gains and losses on sale of subsidiaries. Adjusted EBITDA should not be used to predict IFRS loss as the difference between the two measures is variable and may be significant. babylon

View entire presentation